Skip to main content
SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD logo

SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD — Investor Relations & Filings

Ticker · 000078 ISIN · CNE000000X95 LEI · 300300J4GCOV7CYQTB51 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,616 across all filing types
Latest filing 2024-07-30 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 000078

About SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD

https://www.neptunusbio.com

Shenzhen Neptunus Bioengineering Co., Ltd. is a comprehensive healthcare enterprise focused on the research, development, manufacturing, and distribution of pharmaceutical products. The company operates across the entire industry value chain, including the production of chemical drugs, biological preparations, and traditional Chinese medicines. Its portfolio extends to medical devices and health supplements. A significant component of its operations involves a large-scale pharmaceutical distribution network and a nationwide retail pharmacy chain. The company emphasizes innovation in biotechnology and maintains modern production facilities to support its diverse product lines. By integrating R&D with a robust logistics and retail infrastructure, it provides a wide range of healthcare solutions to medical institutions and consumers.

Recent filings

Filing Released Lang Actions
兴业证券股份有限公司关于深圳市海王生物工程股份有限公司详式权益变动报告书之财务顾问核查意见
Capital/Financing Update Classification · 95% confidence The document is titled as a "详式权益变动报告书之财务顾问核查意见" which translates to "Detailed Equity Change Report - Financial Advisor's Verification Opinion." It references specific regulatory frameworks such as the Securities Law of the People's Republic of China, the Administrative Measures for the Takeover of Listed Companies, and detailed disclosure standards for equity change reports. The content includes detailed verification opinions by a financial advisor on the equity change report, descriptions of the parties involved, shareholding changes, decision-making procedures, and financial data of the involved entities. The document is lengthy (15,000 characters) and contains substantive financial and transactional information related to equity changes, share transfers, voting rights waivers, and new share issuance to specific investors. This aligns with a detailed equity change report rather than a simple announcement or certification. Therefore, the document fits the category of a Capital/Financing Update (CAP), as it deals with changes in share ownership, capital structure, and financing activities related to a listed company.
2024-07-30 Chinese
详式权益变动报告书(广东省广新控股集团有限公司、广东省丝绸纺织集团有限公司)
Major Shareholding Notification Classification · 95% confidence The document is titled as a "详式权益变动报告书" which translates to a "Detailed Equity Change Report." It is issued by Shenzhen Haier Bioengineering Co., Ltd. and involves detailed disclosures about changes in shareholding, including share transfers, voting rights waivers, and subscription to new shares by specific shareholders. The document references relevant securities laws and regulations, such as the Securities Law of the People's Republic of China and the Measures for the Administration of Takeovers of Listed Companies. It contains detailed information about the shareholders, their shareholding percentages before and after the transactions, the purpose of the equity change, decision-making procedures, and financial data of the involved parties. The document is comprehensive and focused on the change in ownership stakes and related transactions. This matches the definition of "Major Shareholding Notification (Code: MRQ)" which covers notifications of changes in significant share ownership levels crossing thresholds. It is not an announcement of a report publication, nor a general regulatory filing, nor a merger/acquisition filing. Therefore, the correct classification is MRQ with high confidence.
2024-07-30 Chinese
关于对外担保进展暨解除对外担保的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Shenzhen Haiwang Bioengineering Co., Ltd. regarding the progress and release of external guarantees. It details the company's guarantee obligations and their current status, including specific financial figures and references to previous related announcements. The content is focused on a specific corporate action related to guarantees and does not contain financial statements, audit opinions, or detailed financial results. It is not a full report like an Annual Report (10-K) or Interim Report (IR), nor is it a regulatory certification or voting result. The document is a formal announcement about a corporate guarantee matter, which fits best under Regulatory Filings (RNS) as it does not fit other more specific categories.
2024-07-30 Chinese
关于控制权转让及权益变动的提示性公告
Major Shareholding Notification Classification · 95% confidence The document is a detailed announcement about a change in control and equity interests of Shenzhen Haier Bioengineering Co., Ltd. It discusses share transfer agreements, voting rights waivers, and subscription agreements for shares issued to specific parties. The content focuses on ownership changes, shareholding percentages, voting rights, and regulatory approvals required for these transactions. There is no financial performance data, earnings information, or management discussion of results. The document is not a report itself but an announcement of a significant equity and control change event. This fits the definition of a Major Shareholding Notification (MRQ) as it notifies about changes in significant share ownership levels and control of the company.
2024-07-30 Chinese
2024年度向特定对象发行A股股票预案
Capital/Financing Update Classification · 95% confidence The document is a detailed plan and proposal for a specific issuance of A shares by Shenzhen Neptunus Bioengineering Co., Ltd. in 2024. It includes extensive information about the issuance background, purpose, pricing, number of shares, involved parties, regulatory approvals required, and the impact on company control and shareholder structure. The document is titled as a "预案" (proposal or plan) for a specific share issuance to designated investors, which aligns with a capital raising or financing activity. It is not a full annual or quarterly report, nor an earnings release or management discussion. It is not a simple announcement or a proxy statement. The content is comprehensive and substantive, describing the capital/financing update in detail. Therefore, the document fits best into the category of Capital/Financing Update (CAP). The document length (15,000 characters) and detailed content support this classification with high confidence.
2024-07-29 Chinese
关于未来三年(2024-2026年)股东分红回报规划
Notice of Dividend Amount Classification · 90% confidence The document is a detailed plan regarding the company's shareholder dividend distribution policy for the years 2024 to 2026. It outlines principles, considerations, and mechanisms for profit distribution, including cash dividends and stock dividends. It references regulatory guidelines from the China Securities Regulatory Commission and the company's articles of association. The document is not a financial report, earnings release, or regulatory filing per se, but rather a formal announcement of the company's dividend policy plan for the next three years. It does not contain financial statements or earnings data, nor is it a brief announcement of dividend amounts for a specific period. Instead, it is a forward-looking policy document about dividends. This fits best under the category of Notice of Dividend Amount (DIV) as it relates to dividend planning and shareholder returns, even though it is a multi-year plan rather than a single dividend announcement. The document length is short (1541 characters), but it contains substantive content about dividend policy rather than just a notice of report publication or a regulatory filing. Therefore, the best classification is DIV with high confidence.
2024-07-29 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.